Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "alexion pharmaceuticals"

HSE considered suing US firm over high price of live-saving drug
Irish Times

HSE considered suing US firm over high price of live-saving drug

Alexion Pharmaceuticals charging €4,557.50 per vial of Soliris for rare blood disorder Photograph: Stephen Kelly/PA Wire. Paul Cullen Topics: News Health Brian Murphy John Hennessy Leo Varadkar Shaun Flanagan Department of Health Health Service ... Irish Times, 1 week ago

26 images for alexion pharmaceuticals

Octafinance, 2 weeks ago
Octafinance, 3 weeks ago
Jutia Group, 1 month ago
Octafinance, 1 month ago
Forbes.com, 2 weeks ago
Forbes.com, 2 weeks ago
Forbes.com, 2 weeks ago
Octafinance, 1 month ago
OTC Outlook, 2 weeks ago
OTC Outlook, 2 weeks ago

Alexion Pharma Q2 Results Beat Estimates, Projects FY15 Earnings Below View

(RTTNews.com) - Alexion Pharmaceuticals, Inc. ( ALXN ) Thursday announced an increase in second quarter net income to $170.22 million from $166.495 million last year. Earnings per share was in line with last year at $0.83. The results included ...
 Nasdaq1 month ago ALEXION PHARMACEUTICALS : Strensiq (asfotase alfa) Gets Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia (HPP)  4 Traders1 month ago Alexion's NDA for hypophosphatasia drug receives MHLW approval  Individual.com1 month ago ALEXION PHARMACEUTICALS' : Strensiq Garners Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia (HPP)  4 Traders1 month ago
[x]  

Alexion Facing Big Costs, Guidance Disappoints

R are-disease specialist Alexion Pharmaceuticals (NASDAQ: ALXN ) beat Q2 estimates Thursday morning, but its stock dropped as its guidance fell short of expectations amid some big costs. Alexion said that its earnings rose 29% over the ...
 Investor's Business Daily1 month ago Amgen, Alexion Q2 Earnings Beat, But Guidance Differs  Investor's Business Daily4 weeks ago Amgen, Alexion Top Views, But Their Outlooks Differ  Yahoo! Singapore4 weeks ago
[x]  
Forbes.com

Costco Wholesale Becomes #45 Most Shorted Nasdaq 100 Component, Replacing Alexion Pharmaceuticals

The most recent short interest data has been released by the NASDAQ for the 07/31/2015 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by days to cover.
 Forbes.com2 weeks ago Alexion Pharmaceuticals Becomes #45 Most Shorted Nasdaq 100 Component, Replacing Wynn Resorts  Market Pulse Navigator1 month ago
[x]  

10-Q - ALEXION PHARMACEUTICALS INC (0000899866) (Filer)

Document Format Files Seq Description Document Type Size 1 10-Q alxn6301510q.htm 10-Q 1650627 2 REGISTRATION RIGHTS AGREEMENT alxnex101.htm EX-10.1 110281 3 CERTIFICATION OF CEO PURSUANT TO SECTION 302 alxnex311q215.htm EX-31.1 12457 4 ...
 SEC4 weeks ago S-8 - ALEXION PHARMACEUTICALS INC (0000899866) (Filer)  SEC1 month ago

Alexion Pharmaceuticals (ALXN) Showing Bullish Technicals With Resistance At $201.60

After closing Friday at $197.44, Alexion Pharmaceuticals Inc ( ALXN ) presents an attractive opportunity to get a 6.88% return in just 109 days, which is an annualized return of 23.05% (for comparison purposes only). To enter this trade, sell one ...
 TradingCharts.com3 weeks ago Potential Alexion Pharmaceuticals (ALXN) Trade Has 6.98% Downside Protection  TradingCharts.com1 month ago
[x]  

Alexion Pharmaceuticals (ALXN) Reaches New Lifetime High Today

Reddit Email Reprint Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Alexion ...
 TheStreet.com1 month ago Alexion Pharmaceuticals (ALXN) Highlighted As Momo Momentum Stock  TheStreet.com1 month ago MYL, REGN And AMGN, 3 Drugs Stocks Pushing The Industry Lower  TheStreet.com3 weeks ago

Alexion Pharmaceuticals Makes a Move: Up 2.2%

Alexion Pharmaceuticals (NASDAQ:ALXN) is one of today's biggest movers, up 2.2% to $196.82. The S&P is trading higher by 0.9% to 2,096 and the Dow is trading 1.1% higher
 Individual.com1 month ago
TheStreet.com

Alexion Pharmaceuticals (ALXN) Stock Gained on Earnings as Guidance Lowered

Reddit Email Print Reprint NEW YORK ( TheStreet ) -- Alexion Pharmaceuticals ( ALXN - Get Report ) shares closed trading up 0.38% to $199.52 on Thursday after the company reported its second quarter earnings results today. The Chesire, ...
 TheStreet.com1 month ago

Alexion Pharmaceuticals Provides Mixed Guidance

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) said it expects 2015 non-GAAP earnings of $4.70 to $4.80 per share on revenue of $2.60 billion to $2.62 billion. The company's previous guidance was earnings of $5.60 to $5.80 per share on revenue of ...
 Individual.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - alexion pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less